3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
16
Thoracic
8
Breast
5
Head & Neck
4
Lymphoid
3
Other hematologic neoplasm
2
Gynecologic
2
Genitourinary
2
Sarcoma
1
Myeloid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
874
Precursor Cell Lymphoblastic Leukemia-Lymphoma
499
Hematologic Neoplasms
462
Leukemia, Lymphocytic, Chronic, B-Cell
388
Leukemia
328
Myelodysplastic Syndromes
324
Lymphoma
203
Lymphoma, Non-Hodgkin
191
Multiple Myeloma
145
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
139
Recurrence
136
Neoplasms
133
Leukemia, Myelomonocytic, Chronic
110
Burkitt Lymphoma
92
Lymphoma, Mantle-Cell
91
Lymphoma, Follicular
91
Lymphoma, Large B-Cell, Diffuse
88
Myeloproliferative Disorders
84
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
81
Leukemia, Biphenotypic, Acute
79
Lymphoma, B-Cell, Marginal Zone
75
Hodgkin Disease
72
Lymphoma, B-Cell
64
Waldenstrom Macroglobulinemia
54
Primary Myelofibrosis
53
Leukemia, B-Cell
50
Anemia, Refractory, with Excess of Blasts
45
Leukemia, Myeloid, Chronic-Phase
40
Hematologic Diseases
37
Lymphoma, T-Cell
32
Interventions
nicotinamide-beta-riboside
1
Wearable Electronic Devices
1
Exercise
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Sarcopenia
×
Other hematologic neoplasm
×
1 year
×
Clear all
NCT07325305
2026-04-13
PROTECT
Murdoch Childrens Research Institute
Phase NA
Recruiting
60 enrolled
NCT05194397
2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2
Recruiting
80 enrolled